-+ 0.00%
-+ 0.00%
-+ 0.00%
3 European Stocks Estimated To Be Up To 47.3% Below Intrinsic Value
Share
Listen to the news

The European stock market has shown mixed performance recently, with the pan-European STOXX Europe 600 Index ending the week slightly up and economic sentiment in the eurozone improving for a fourth consecutive month. Amid these conditions, investors are on the lookout for undervalued stocks that could offer potential value as they navigate through varied economic data and geopolitical developments. Identifying such stocks often involves assessing their intrinsic value relative to current market prices, providing opportunities for those seeking to capitalize on perceived discrepancies in valuation.

Top 10 Undervalued Stocks Based On Cash Flows In Europe

Name Current Price Fair Value (Est) Discount (Est)
Verisure (OM:VSURE) €8.90 €17.67 49.6%
STMicroelectronics (ENXTPA:STMPA) €43.015 €85.60 49.7%
RTL Group (XTRA:RRTL) €32.05 €64.08 50%
RaySearch Laboratories (OM:RAY B) SEK180.40 SEK357.57 49.5%
PSI Software (XTRA:PSAN) €45.00 €88.97 49.4%
Metriks AI. Società Benefit (BIT:MTK) €3.40 €6.79 49.9%
Lime Technologies (OM:LIME) SEK258.00 SEK512.67 49.7%
Dynavox Group (OM:DYVOX) SEK74.80 SEK149.24 49.9%
Cicor Technologies (SWX:CICN) CHF127.40 CHF254.38 49.9%
Bénéteau (ENXTPA:BEN) €5.83 €11.59 49.7%

Click here to see the full list of 214 stocks from our Undervalued European Stocks Based On Cash Flows screener.

Let's uncover some gems from our specialized screener.

Demant (CPSE:DEMANT)

Overview: Demant A/S is a hearing healthcare company with operations across Europe, North America, Asia, the Pacific region, and internationally, and has a market cap of DKK60.87 billion.

Operations: The company generates revenue of DKK24.63 billion from its Hearing Healthcare segment across various regions including Europe, North America, Asia, and the Pacific.

Estimated Discount To Fair Value: 47.3%

Demant is trading at DKK288.6, significantly below its estimated future cash flow value of DKK547.47, suggesting it is undervalued by over 20%. The company's recent launch of the Oticon Reveal hearing aid could bolster sales growth, with H1 2026 sales reaching DKK12.91 billion compared to last year's DKK11.25 billion. Despite high debt levels, Demant's earnings are forecast to grow annually at 13.5%, outpacing the Danish market rate of 6.9%.

CPSE:DEMANT Discounted Cash Flow as at Sep 2026
CPSE:DEMANT Discounted Cash Flow as at Sep 2026

Straumann Holding (SWX:STMN)

Overview: Straumann Holding AG is a global provider of tooth replacement and orthodontic solutions, with operations in countries including Switzerland, the United States, China, and Germany, and has a market cap of CHF14.97 billion.

Operations: Straumann Holding AG's revenue is segmented into CHF1.31 billion from operations, CHF630.19 million from sales in Asia Pacific, CHF740.35 million from North America, CHF337.34 million from Latin America, and CHF1.14 billion from Europe, Middle East and Africa.

Estimated Discount To Fair Value: 41.5%

Straumann Holding, trading at CHF93.9, is undervalued relative to its estimated future cash flow value of CHF160.63. The company anticipates earnings growth of 16.8% annually, surpassing the Swiss market's 12.3%. Revenue is projected to grow at 9.7% per year, above the market rate of 5.3%. Recent leadership changes see Christopher Norbye taking over as CEO in December 2026 following Guillaume Daniellot’s departure after two decades with Straumann.

SWX:STMN Discounted Cash Flow as at Sep 2026
SWX:STMN Discounted Cash Flow as at Sep 2026

Allegro.eu (WSE:ALE)

Overview: Allegro.eu S.A. operates a commerce platform for consumers in Poland, Czech Republic, Slovakia, Hungary, and internationally with a market cap of PLN44.64 billion.

Operations: The company's revenue segments include Allegro International, generating PLN556.10 million.

Estimated Discount To Fair Value: 25.4%

Allegro.eu, trading at PLN45.61, is undervalued compared to its estimated future cash flow value of PLN61.15. Earnings are expected to grow 14.9% annually, outpacing the Polish market's 11%. While revenue growth is forecasted at 10.6% per year—slower than significant benchmarks—it still exceeds the national average of 4.8%. Recent amendments in company bylaws reflect a reduction in share capital and updated board composition guidelines, enhancing governance flexibility.

WSE:ALE Discounted Cash Flow as at Sep 2026
WSE:ALE Discounted Cash Flow as at Sep 2026

Where To Now?

Contemplating Other Strategies?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending